Education · Startup Funding
Most founders start with the wrong question. They ask, "What is my company worth?" The better question is, "What will this money be able to prove is true?" This page walks through how a capital raise actually works, why companies raise in stages, what investors expect at each stage, how founders decide how much to raise — and why a company's value is really the story of risk being converted into evidence.
The Principle
At the centre of this page is one idea, and every other section serves it: an investor should not primarily be financing an idea. They are financing a defined process that converts identifiable risks into measurable enterprise value. An early company is priced the way it is partly because the market is uncertain about a long list of things. Each question mark on that list is a reason the valuation is low. Each one that gets answered with evidence is a reason it can grow.
What a new company is uncertain about — and what the capital is there to resolve — spans a broad set of risks. Tap each category to open it.
Technical risk — Does the product actually work as designed, and can it be built to perform? Product risk — Is what we plan to make the thing people actually want to use?
IP risk — Do we own what we need to own, and can we stop others from copying it? Regulatory risk — Will approvals, standards and the law let us bring it to market?
Market risk — Does a real market exist, and how large is the obtainable share? Pricing risk — Will customers pay a price that produces a workable margin? Customer-acquisition risk — Can we find and sign customers at a cost below what they return?
Manufacturing risk — Can we actually produce it at a cost, quality and volume that works? Execution risk — Is this team able to do what the plan requires? Financing risk — Will more capital be available at the point the company needs it?
The Mechanics
Let's walk through the arithmetic of a single round with a simple fictional company, NewCo. The numbers are deliberately round. What matters is the structure of the transaction, because that structure repeats at every stage of a company's life.
Illustrative figures to show the mechanics, not a market appraisal.
Two terms matter, and they are worth distinguishing clearly.
In the example above, the $500,000 goes into the company — to pay for the engineering, the testing, the manufacturing, the work. It does not go into the founders' pockets. The founders gained value by owning 80% of a company that is now worth more.
Separately, an investor can acquire shares that a founder already holds. In that case the money goes to the selling shareholder, not to the company. This is common in later stages, but in an early-stage raise it is normally the wrong place to start — because early capital should be buying the company the work it needs, not buying the founders out of their own risk.
Play With the Numbers
The best way to feel how a round works is to change the numbers. Adjust the single-round inputs below, or model a few rounds of staged dilution. These are illustrative — they ignore option pools and converting instruments, so use them to learn the shape of the maths, not as a cap-table tool.
The Why
Consider a company that expects to need about $20 million in total before it reaches real scale. A reasonable instinct might be, "Then raise all of it now." In practice, doing so is usually a mistake. The reason comes back to the relationship between value and proof: the company is worth more later, after it has replaced assumptions with evidence — so founders who wait can give away less ownership for the later dollars.
Illustrative example of the staged principle.
The Roadmap
Every stage of financing exists to answer one central question before the next stage is earned. The questions are cumulative: you do not skip to "can this scale?" until you have first answered "is this a repeatable business?"
The core question: is there an opportunity worth pursuing at all? Before outside investors finance meaningful development, founders normally establish the basics — the problem, the proposed solution, who the customer is, why there is an opportunity, and a rough sense of the economics. Concept-stage money is usually the founder's own time and cash, or friends and family. Outside investors expect to see at least the shape of an opportunity, not just an enthusiasm.
The core question: can we turn this idea into something real and potentially commercial? This stage typically funds a prototype or MVP, initial technical validation, market discovery, early IP work, and customer discovery. Investors here want to see that the concept can become a tangible thing people might actually want.
The core question: can this become a repeatable business? Now the money funds paying customers, pilots, early revenue, pricing, production or delivery, regulatory progress, unit economics, and customer acquisition. The evidence sought is repeatability — that the deal works more than once, for more than one customer, at a price that covers cost.
The core question: can this business scale? Series A looks for meaningful traction — real revenue, working margins, acquisition and retention data, a management team, systems, sales capacity, and production capacity. The money is for scaling something already proven to work, and investors expect the operating discipline that scaling demands.
The core question: the machine appears to work — how aggressively can it be scaled? Series B is about growth at speed: bigger sales organizations, expansions, deeper production, more markets. The evidence already exists; the capital accelerates the machine that produced it.
The core question: how large and strategically valuable can this company become? Later rounds fund expansion into new markets and categories, acquisitions, and moves toward a public listing or a large strategic outcome. The company is now a proven, scaled business deciding how big it wants to be.
A quick comparison of the stages, read together.
| Stage | What has been proven | Main remaining risk | Typical purpose of capital | What should be proven next |
|---|---|---|---|---|
| Pre-Seed | Little beyond the concept and a prototype | Is the idea even real and wanted? | Prototype / MVP and initial validation | A product a first customer might use |
| Seed | A working product and early interest | Is it a repeatable business? | Pilots, early revenue, unit economics | Repeatability and real pricing |
| Series A | Repeatable revenue and working economics | Does it still work at scale? | Sales, systems, production capacity | Scalable, growing, efficient operation |
| Series B | A machine that demonstrably works | How far and how fast can it grow? | Aggressive expansion and acceleration | Market leadership and efficiency |
| Series C + | A scaled, proven business | How strategically large can it become? | New markets, acquisitions, exit pathway | Maximum scale and value |
The Screening
Before money changes hands, an investor runs an opportunity through a practical filter — part common sense, part arithmetic. You can run the same filter on your own idea before you go looking. A useful version of that ladder looks like this:
Problem → Solution → Customer → Buyer → Monetisation → Economics → Defensibility → Execution → Scale → Investor Return.
The Moat
A patent is commonly described as a "moat." It is safer to say a patent can contribute to a moat. Legal protection and commercial defensibility are two different things, and conflating them is a common early mistake.
A patent gives the holder the right to try to stop others from practising the claimed invention for a limited time. That is real, but it is only one ingredient. A claim is only as strong as its drafting, its validity, and the holder's willingness and money to enforce it.
The practical question is whether the company can hold its position against competitors. That can rest on many things — and often rests on several at once.
Defensibility can come from far more than a patent. The sources are best considered as a list worth checking, not a single box to tick:
The Threshold
There is no universal rule such as "Pre-Seed requires one patent." The right amount of IP preparation depends on the industry, the technology, how easily the idea could leak, the competitive environment, how central the IP is to the valuation, and the stage of the financing. What investors generally want is certainty of ownership and a credible strategy.
| Stage | Reasonable IP posture |
|---|---|
| Pre-Seed | Enough protection and ownership certainty to safely finance validation — clean founder assignments and basic confidentiality in place. |
| Seed | Clear ownership, written assignments from all contributors, an articulated strategy, and appropriate filings or protections underway. |
| Series A | IP should increasingly withstand serious investor due diligence — filings progressing, trade secrets controlled, freedom-to-operate considered. |
The practical checklist an investor will probe:
The Use of Funds
There is a meaningful difference between capital that creates enterprise value and capital that primarily benefits the founders personally. Investors think about this distinction from the moment they read a use-of-funds schedule. They are not being unreasonable; they are checking that the money buys progress.
Reasonable uses of capital include:
Building the product itself.
Turning the concept into something tangible, and proving it works.
Earning approvals and clearances.
Protecting and owning the asset.
Producing it at scale.
Proving people will pay.
Hiring the people the plan needs.
Running the business and a reserve for the unexpected.
Reasonable founder compensation deserves a clear word: founders are normally paid a salary, and that salary is legitimate, because a founder who must work full-time is expected to be able to live. The line is crossed when compensation stops being about making the business work and becomes a way of personally benefiting from the idea itself.
A market-rate founder salary that lets them work full-time, without personal drawdowns beyond what the work justifies.
Excessive founder salaries, bonuses unrelated to performance, personal or lifestyle expenses, unnecessary vehicles or travel, substantial early founder liquidity, or effectively paying founders simply for having had the idea.
The Map
Do not characterise early-stage investing as "low risk." It is not, and pretending otherwise undermines your credibility. The opposite approach is more powerful: identify the risks openly, and show exactly how the capital addresses each one. Investors respect a founder who can name their own uncertainties, because it proves they see the game clearly.
A founding team might honestly describe the company today like this:
Then the raise is presented not as a pile of money, but as a plan to convert those question marks into checkmarks. For example:
Illustrative allocation.
Beyond the economics, investors also hold rights and protections that shift how risk is shared. Two very different categories are worth keeping separate:
How the company itself is expected to de-risk the business — the engineering, testing, regulatory, market and manufacturing plans. This is where real value is created.
The legal mechanisms that protect the investor: milestone or tranched funding, board representation, information rights, preferred shares, liquidation preferences, founder vesting, pro-rata rights, and reserved matters.
The Method
This is the most practical section on the page, and it is worth reading slowly. Management should not begin with "We want to raise $2 million," and then invent a use-of-funds schedule to justify a number chosen first. The credible approach is to work in reverse — from the next milestone backward to the amount required.
Determine what the company needs to look like at the next financing — the concrete state you want to have reached.
Determine what the next group of investors will reasonably expect to see before they would invest.
Compare those requirements with where the company sits today.
Identify the specific gaps between the two.
Determine what activities are required to close those gaps.
Cost those activities as precisely as you reasonably can.
Add reasonable contingency and runway — the cash that keeps you safe while you work.
Determine the resulting required raise — the figure you genuinely need, defended by the plan that produced it.
Now evaluate the outcome against the consequences it creates:
A numerical example ties the method together.
Illustrative example.
The Model
This is the idea at the centre of the page, made concrete. The model runs: Identifiable Risk → Capital → Defined Activity → Evidence → Reduced Uncertainty → Enterprise Value. Every line of every plan should, in principle, be traceable along this chain.
The Hidden Discount
Most founders learn this too late, which is exactly why it belongs on this page. When a company wants to pay future employees with equity, it creates an option pool — a block of shares reserved for hiring. The trap is the question of when that pool is created relative to the investment, because it decides who absorbs the dilution.
The pool is carved out of the pre-money value — before the new money is added. Because it comes out of the existing owners' share, the founders alone absorb the dilution of the pool. This is the standard request in most term sheets.
The pool is created after the investment is priced, so the new investor and all existing holders share its dilution proportionally. It costs the founders less. This is the part worth negotiating.
Here is why the distinction matters, in numbers.
Illustrative example.
The Trade-Off
Dilution is the reduction in a founder's ownership percentage as new shares are issued. It is sometimes described as if it were a loss. It is better understood as a trade: ownership percentage is given up in exchange for value created by the capital.
As a purely illustrative path, a founder might move through the stages like this (these figures are examples only, not a prediction — and the calculator above lets you generate your own):
The Test
Every raise, reduced to its essence, comes down to one question. If a founder can answer it clearly and specifically, the raise is properly structured. If not, the raise may not actually be ready.
A founder who cannot answer this has not yet fully structured the raise. Then the question is inverted — the founder should ask it of themselves and their own company:
The Process
No guide to fundraising is honest without the parts nobody enjoys. Here is what the process typically looks like beyond the theory — so you don't mistake the mundane work for failure.
A serious round frequently runs 3–6 months or more from first outreach to money in the bank — and that is after the months of preparation before it. Expect a concentrated fundraising effort, often dozens of calls and meetings, layered on top of actually running the business.
Incorporation, the cap table, financing documents and legal work commonly run into the tens of thousands of dollars, and the cost grows with complexity. Factor this into the use of funds — raising capital is not free, and the professionals must be paid.
A founder will hear far more refusals than acceptances, and many will not be about the quality of the idea at all — timing, fund mandate, check size, or simply that investing is a numbers game. A wall of no's is not proof of failure; it is the ordinary texture of the process.
After interest comes diligence — 2–4 weeks of review over the cap table, IP, contracts, financials and team. A clean, organised data room shortens it. An unprepared one invites delay and renegotiation.
Fundraising from a position of low runway is raising from weakness. Investors feel it, and terms get harder. Begin the process while you still have meaningful runway left, so the ask is an opportunity rather than a rescue.
Capital may be wired all at once or in tranches tied to milestones. Understand the schedule before you sign, and make sure the runway works with the timing of each instalment, not just the total.
Watch It Happen
To tie every concept on this page together, follow one fictional company — OneCo — from a single idea to a funded, scaling business, and watch the risk-to-value machine work at each step.
OneCo's founder has an idea for a device that solves a painful, common problem. No outside money yet. With personal cash and time, she builds a rough prototype and talks to a handful of potential users. Two problems stand out: they understand it, and they ask when it will be available. She has concept-stage evidence — a problem, a solution, and early interest — but nothing more.
OneCo raises $500k at a $2M valuation (the NewCo maths from earlier). The money goes to engineering a proper prototype, early technical validation, and a trademark plus a provisional patent. Eleven months later, OneCo has a working prototype, clean ownership of its IP, and documented early customer interest. Technical risk partly retired; ownership certainty established.
The founder builds the raise backwards: to reach a Series-A-ready state she needs real revenue, repeatable customers and regulated, manufacturable production. Closing that gap costs roughly $2M. She raises it at a valuation that has risen to $5M because the prototype is real and the ownership is clean. The capital buys engineering, regulatory testing, manufacturing validation and a pilot sales effort. Two years on: 20 paying customers, a verified per-unit cost, and a regulatory approval submitted.
With a repeatable sale, working unit economics and a product that can be made at scale, OneCo raises at a materially higher valuation than its seed. The money funds sales capacity, systems and production volume — the machine is proven, so the capital accelerates it rather than rescuing it. The investor's final question from earlier sections is answerable in one line: "Eighteen months ago this company could not be manufactured, sold or regulated at scale. Now it can, to paying, repeatable customers — and that is why my ownership is worth more."
The Takeaway
A funding round is not simply money placed into a company. It is an exchange: investor capital today, for ownership in the future value management believes it can create. Everything on this page is in service of that exchange being honest and well-constructed.
The responsibility of management is therefore to be able to explain:
The Language
The terms of venture finance are scattered through every conversation. Here they are, defined simply, grouped by where you meet them.
What the company is worth
The value of a company judged before the new investment is added.
The value after the new investment is added — pre-money plus the new capital.
The reduction in a shareholder's ownership percentage as new shares are issued.
The ledger of who owns what — the record of a company's ownership.
Ownership calculated as if every option, warrant and convertible had already converted — the fair basis for comparison.
A raise priced at a lower (down) or higher (up) valuation than the previous round.
How early money is structured
A Simple Agreement for Future Equity — a document that gives an investor the right to shares in a later financing, often with a valuation cap.
A loan that converts into equity at a later financing, typically with interest and often a discount or cap.
The maximum price at which an early instrument converts — capping how much of the company the early investor pays for.
Preferred shares carry rights and protections (usually investors); common shares are typically held by founders and employees.
Shares reserved to compensate future employees — its size and when it is created affect founder dilution.
The non-binding outline of a deal's key terms, which frames the legal documents that follow.
The runway
How much cash the company spends per month.
How many months the company can keep operating on the cash it has.
A defined, measurable outcome the capital is expected to achieve.
The revenue and cost of a single customer or unit of sale — whether the maths works before scale.
Revenue minus the direct cost of delivering, as a percentage.
A reserved buffer of capital for what the plan gets wrong.
The contract
Who gets paid first, and how much, if the company is sold or wound down.
Equity that is earned over time, so a departing founder does not leave with everything.
A holder's right to invest again in later rounds to maintain their ownership percentage.
Key decisions requiring investor approval — where control is partly shared.
An investor's right to regular reports on the company's performance.
The seat, or seats, an investor is entitled to on the board of directors.